Nai-Jen Liu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Nai-Jen Liu has a total of 18 co-authors. Here are the top co-authors by number of shared publications:
- Chi-Liang Cheng
Division of Gastroenterology, Department of Medicine, Evergreen General Hospital, Taoyuan, Taiwan
2 shared publications - Yen-Lin Kuo
Division of Gastroenterology, Evergreen General Hospital, Taoyuan, Taiwan
2 shared publications - Bai-Ping Lee
Division of Gastroenterology, Evergreen General Hospital, Taoyuan, Taiwan, ROC
1 shared publication - Cheng-Han Xie
Department of Gastroenterology and Hepatology, Chang-Gung Memorial Hospital and University, Keelung 204, Taiwan
1 shared publication - Chi-Huan Wu
Department of Gastroenterology and Hepatology, Linkou Chang Gung Memorial Hospital, Taoyuan 333, Taiwan
1 shared publication - Chia-Pei Tang
Division of Gastroenterology, Department of Internal Medicine, Dalin Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Chiayi 622401, Taiwan
1 shared publication
Latest Publications
- Open Access
- 4 May 2023
- Published by Wolters Kluwer Health in Clinical and Translational Gastroenterology
- Vol. 14 (7) , e00594
Randomized Trial Comparing Left Colon Mucus Production Using Water vs Saline During Water Exchange Colonoscopy
INTRODUCTION: Water-assisted colonoscopy increases left colon mucus production; however, the effect of saline on mucus production is unclear. We tested the hypothesis that saline infusion may reduce mucus production in a dose-related manner. METHODS: In a randomized trial, patients were assigned to colonoscopy with CO2 insufflation, water exchange (WE) with warm water, 25% saline, or 50% saline. The primary outcome was the Left Colon Mucus Scale (LCMS) score (5-point scale). Blood electrolytes were measured before and after saline infusion. RESULTS: A total of 296 patients with similar baseline demographics were included. The mean LCMS score for WE with water was significantly higher than that for WE with saline and CO2 (1.4 ± 0.8 [WE water] vs 0.7 ± 0.6 [WE 25% saline] vs 0.5 ± 0.5 [WE 50% saline] vs 0.2 ± 0.4 [CO2]; overall P < 0.0001), with no significant difference between the 25% and 50% saline groups. The left colon adenoma detection rate (ADR) was highest in the 50% saline group, followed by the 25% saline and the water groups (25.0% vs 18.7% vs 13.3%), but the difference was not significant. Logistic regression showed water infusion as the only predictor of moderate mucus production (odds ratio 33.3, 95% confidence interval 7.2–153.2). No acute electrolyte abnormalities were documented indicating a safe modification. DISCUSSION: The use of 25% and 50% saline significantly inhibited mucus production and numerically increased ADR in the left colon. Evaluation of the impact of mucus inhibition by saline on ADR may refine the outcomes of WE.
- 4 May 2023
- Published by Wolters Kluwer Health in Clinical and Translational Gastroenterology
- Vol. 14 (7) , e00594
Open AccessRandomized Trial Comparing Left Colon Mucus Production Using Water vs Saline During Water Exchange Colonoscopy
INTRODUCTION: Water-assisted colonoscopy increases left colon mucus production; however, the effect of saline on mucus production is unclear. We tested the hypothesis that saline infusion may reduce mucus production in a dose-related manner. METHODS: In a randomized trial, patients were assigned to colonoscopy with CO2 insufflation, water exchange (WE) with warm water, 25% saline, or 50% saline. The primary outcome was the Left Colon Mucus Scale (LCMS) score (5-point scale). Blood electrolytes were measured before and after saline infusion. RESULTS: A total of 296 patients with similar baseline demographics were included. The mean LCMS score for WE with water was significantly higher than that for WE with saline and CO2 (1.4 ± 0.8 [WE water] vs 0.7 ± 0.6 [WE 25% saline] vs 0.5 ± 0.5 [WE 50% saline] vs 0.2 ± 0.4 [CO2]; overall P < 0.0001), with no significant difference between the 25% and 50% saline groups. The left colon adenoma detection rate (ADR) was highest in the 50% saline group, followed by the 25% saline and the water groups (25.0% vs 18.7% vs 13.3%), but the difference was not significant. Logistic regression showed water infusion as the only predictor of moderate mucus production (odds ratio 33.3, 95% confidence interval 7.2–153.2). No acute electrolyte abnormalities were documented indicating a safe modification. DISCUSSION: The use of 25% and 50% saline significantly inhibited mucus production and numerically increased ADR in the left colon. Evaluation of the impact of mucus inhibition by saline on ADR may refine the outcomes of WE.
- 5 July 2022
- Published by Springer Nature in Digestive Diseases and Sciences
- Vol. 68 (1) , 259-267
Risk of Metachronous Advanced Colorectal Neoplasia After Removal of Diminutive Versus Small Nonadvanced Adenomas: A Multicenter Study
Background Current postpolypectomy guidelines treat 1–9 mm nonadvanced adenomas (NAAs) as carrying the same level of risk for metachronous advanced colorectal neoplasia (ACRN). Aims To evaluate whether small (6–9 mm) NAAs are associated with a greater risk of metachronous ACRN than diminutive (1–5 mm) NAAs. Methods We retrospectively evaluated 10,060 index colonoscopies performed from July 2011 to June 2019. A total of 1369 patients aged ≥ 40 years with index NAAs and having follow-up examinations were categorized into 5 groups based on size and number of index findings: Group 1, ≤ 2 diminutive NAAs (n = 655); Group 2, ≤ 2 small NAAs (n = 529); Group 3, 3–4 diminutive NAAs (n = 78); Group 4, 3–4 small NAAs (n = 65); and Group 5, 5–10 NAAs (n = 42). Size was classified based on the largest NAA. ACRN was defined as finding an advanced adenoma or colorectal cancer at follow-up. Results The absolute risk of metachronous ACRN increased from 7.2% in patients with all diminutive NAAs to 12.2% in patients with at least 1 small NAA (P = 0.002). Patients in Group 2 (adjusted odds ratio [AOR] 1.89; 95% confidence interval [CI], 1.21–2.95), Group 3 (AOR 2.40; 95% CI 1.78–4.90), Group 4 (AOR 2.77; 95% CI 1.35–5.66), and Group 5 (AOR 3.71; 95% CI 1.65–8.37) were associated with an increased risk of metachronous ACRN compared with Group 1. Conclusions Patients with small NAAs have an increased risk of metachronous ACRN. Postpolypectomy guidelines should consider including risk stratification between small and diminutive adenomas.
- 5 July 2022
- Published by Springer Nature in Digestive Diseases and Sciences
- Vol. 68 (1) , 259-267
Risk of Metachronous Advanced Colorectal Neoplasia After Removal of Diminutive Versus Small Nonadvanced Adenomas: A Multicenter Study
Background Current postpolypectomy guidelines treat 1–9 mm nonadvanced adenomas (NAAs) as carrying the same level of risk for metachronous advanced colorectal neoplasia (ACRN). Aims To evaluate whether small (6–9 mm) NAAs are associated with a greater risk of metachronous ACRN than diminutive (1–5 mm) NAAs. Methods We retrospectively evaluated 10,060 index colonoscopies performed from July 2011 to June 2019. A total of 1369 patients aged ≥ 40 years with index NAAs and having follow-up examinations were categorized into 5 groups based on size and number of index findings: Group 1, ≤ 2 diminutive NAAs (n = 655); Group 2, ≤ 2 small NAAs (n = 529); Group 3, 3–4 diminutive NAAs (n = 78); Group 4, 3–4 small NAAs (n = 65); and Group 5, 5–10 NAAs (n = 42). Size was classified based on the largest NAA. ACRN was defined as finding an advanced adenoma or colorectal cancer at follow-up. Results The absolute risk of metachronous ACRN increased from 7.2% in patients with all diminutive NAAs to 12.2% in patients with at least 1 small NAA (P = 0.002). Patients in Group 2 (adjusted odds ratio [AOR] 1.89; 95% confidence interval [CI], 1.21–2.95), Group 3 (AOR 2.40; 95% CI 1.78–4.90), Group 4 (AOR 2.77; 95% CI 1.35–5.66), and Group 5 (AOR 3.71; 95% CI 1.65–8.37) were associated with an increased risk of metachronous ACRN compared with Group 1. Conclusions Patients with small NAAs have an increased risk of metachronous ACRN. Postpolypectomy guidelines should consider including risk stratification between small and diminutive adenomas.